| William Jordan Gottschalk, DO | |
|
1135 Lake Ave, Clermont, FL 34711-3037 | |
| (352) 394-4035 | |
| (352) 394-8585 |
| Full Name | William Jordan Gottschalk |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 1135 Lake Ave, Clermont, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306231873 | NPI | - | NPPES |
| 025120200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS15396 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Adventhealth Fish Memorial | Orange city, FL | Hospital |
| Adventhealth Deland | Deland, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Hospital Medical Group Inc | 0749186153 | 1163 |
| Adventhealth Primary Care Network Inc | 1557722410 | 204 |
News Archive
In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such as the use of proton pump inhibitors (PPIs) and the substantial increase in antibiotic use due to new National Hospital Quality Measures; strategies to combat high rates of C. difficile infections; and cutting‐edge treatments for this potentially deadly-and quite common-infection.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
Scientists have developed an easy-to-use software tool that can detect important genetic mutations that previously needed to be identified by a separate test.
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death.
› Verified 5 days ago
| Entity Name | Florida Hospital Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225034234 PECOS PAC ID: 0749186153 Enrollment ID: O20031208000807 |
News Archive
In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such as the use of proton pump inhibitors (PPIs) and the substantial increase in antibiotic use due to new National Hospital Quality Measures; strategies to combat high rates of C. difficile infections; and cutting‐edge treatments for this potentially deadly-and quite common-infection.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
Scientists have developed an easy-to-use software tool that can detect important genetic mutations that previously needed to be identified by a separate test.
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death.
› Verified 5 days ago
| Entity Name | Clermont Medical Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861557357 PECOS PAC ID: 9830146737 Enrollment ID: O20050404000139 |
News Archive
In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such as the use of proton pump inhibitors (PPIs) and the substantial increase in antibiotic use due to new National Hospital Quality Measures; strategies to combat high rates of C. difficile infections; and cutting‐edge treatments for this potentially deadly-and quite common-infection.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
Scientists have developed an easy-to-use software tool that can detect important genetic mutations that previously needed to be identified by a separate test.
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death.
› Verified 5 days ago
| Entity Name | Urgent Care Centers Of Brevard County Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295367290 PECOS PAC ID: 6002238714 Enrollment ID: O20200626000122 |
News Archive
In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such as the use of proton pump inhibitors (PPIs) and the substantial increase in antibiotic use due to new National Hospital Quality Measures; strategies to combat high rates of C. difficile infections; and cutting‐edge treatments for this potentially deadly-and quite common-infection.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
Scientists have developed an easy-to-use software tool that can detect important genetic mutations that previously needed to be identified by a separate test.
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death.
› Verified 5 days ago
| Entity Name | Adventhealth Primary Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093493637 PECOS PAC ID: 1557722410 Enrollment ID: O20230725004134 |
News Archive
In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such as the use of proton pump inhibitors (PPIs) and the substantial increase in antibiotic use due to new National Hospital Quality Measures; strategies to combat high rates of C. difficile infections; and cutting‐edge treatments for this potentially deadly-and quite common-infection.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
Scientists have developed an easy-to-use software tool that can detect important genetic mutations that previously needed to be identified by a separate test.
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Jordan Gottschalk, DO 1135 Lake Ave, Clermont, FL 34711-3037 Ph: (352) 394-4035 | William Jordan Gottschalk, DO 1135 Lake Ave, Clermont, FL 34711-3037 Ph: (352) 394-4035 |
News Archive
In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such as the use of proton pump inhibitors (PPIs) and the substantial increase in antibiotic use due to new National Hospital Quality Measures; strategies to combat high rates of C. difficile infections; and cutting‐edge treatments for this potentially deadly-and quite common-infection.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
Scientists have developed an easy-to-use software tool that can detect important genetic mutations that previously needed to be identified by a separate test.
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death.
› Verified 5 days ago
Dr. Judith A. Moss, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17325 Pagonia Rd, Clermont, FL 34711 Phone: 407-905-6006 Fax: 407-636-7806 | |
Jaison John, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1900 Don Wickham Dr, Clermont, FL 34711 Phone: 352-394-4071 | |
Dr. Rahila N Chaudhry, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1900 Don Wickham Dr, Mp Sl Admin, Clermont, FL 34711 Phone: 352-536-8840 Fax: 352-536-8841 | |
Dr. Jorge Ribet, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1735 E Highway 50 Ste B, Clermont, FL 34711 Phone: 352-241-0549 Fax: 352-242-9325 | |
Aashiv Hari, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 Oakley Seaver Dr, Clermont, FL 34711 Phone: 352-536-1764 | |
Naseem S Paruk, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1900 Don Wickham Dr, Clermont, FL 34711 Phone: 352-536-8840 Fax: 352-536-8841 | |
Mrs. Jessica Ramona Curry, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1919 E Hwy 50 Ste 205, Clermont, FL 34711 Phone: 352-717-3760 |